Australia markets close in 2 hours 44 minutes

Hepion Pharmaceuticals, Inc. (336.MU)

Munich - Munich Delayed price. Currency in EUR
Add to watchlist
1.4200-0.0300 (-2.07%)
At close: 07:20PM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
35,640
35,640
33,269
20,395
11,997
Selling general and administrative
9,618
9,618
10,348
10,008
8,149
Total operating expenses
45,258
45,258
43,618
30,403
20,146
Operating income or loss
-45,258
-45,258
-43,618
-30,403
-20,146
Interest expense
9.465
9.465
10.164
8.859
31.229
Total other income/expenses net
-4,068
-4,068
-1,456
-2,310
-146.05
Income before tax
-49,335
-49,335
-45,084
-32,722
-20,323
Income tax expense
-409.022
-409.022
-2,884
0
30.584
Income from continuing operations
-48,926
-48,926
-42,200
-32,722
-20,354
Net income
-48,926
-48,926
-42,200
-32,722
-20,354
Net income available to common shareholders
-48,926
-48,926
-45,338
-32,722
-20,359
Basic EPS
-12.42
-12.32
-11.90
-9.40
-42.00
Diluted EPS
-12.42
-12.32
-11.90
-9.40
-42.00
Basic average shares
3,822
3,971
3,811
3,515
483.891
Diluted average shares
3,822
3,971
3,811
3,515
483.891